Close
  Indian J Med Microbiol
 

Figure 2: (a) (A1-A3) Representative dot plots of CD19 + cells in three patients with NR, PR, and CR. (A4) Lower expression percentage of CD19 in lymphocytes of NR (19.80 ± 3.24) with no significant difference (P = 0.993) compared with CR (25.41 ± 2.29) patients. (b) (B1-B3) Representative dot plots of CD20 + cells in three patients with NR, PR, and CR. (B4) Statistically significant expression of CD20 percentage in lymphocytes of NR (27.30 ± 8.70) compared with CR (15.20 ± 8.46) patients with significant difference (P = 0.015). (c) (C1-C3) Representative dot plots of CD25 + cells in three patients with NR, PR, and CR. (C4) CD25 expression in lymphocytes of NR patients is lower (3.21 ± 2.81) than CR (4.86 ± 1.23) with no significant difference (P = 0.369)

Figure 2: (a) (A1-A3) Representative dot plots of CD19 + cells in three patients with NR, PR, and CR. (A4) Lower expression percentage of CD19 in lymphocytes of NR (19.80 ± 3.24) with no significant difference (<i>P</i> = 0.993) compared with CR (25.41 ± 2.29) patients. (b) (B1-B3) Representative dot plots of CD20 + cells in three patients with NR, PR, and CR. (B4) Statistically significant expression of CD20 percentage in lymphocytes of NR (27.30 ± 8.70) compared with CR (15.20 ± 8.46) patients with significant difference (<i>P</i> = 0.015). (c) (C1-C3) Representative dot plots of CD25 + cells in three patients with NR, PR, and CR. (C4) CD25 expression in lymphocytes of NR patients is lower (3.21 ± 2.81) than CR (4.86 ± 1.23) with no significant difference (<i>P</i> = 0.369)